Newsroom Page

Press Release May 19, 2026

Leading NCI-Designated Cancer Centers Across the Country Leverage ConcertAI’s CancerLinQ to Support Personalized, Evidence-Based Quality Care

Press Release May 11, 2026

ConcertAI Appoints Shawn W. Bates as General Manager, Commercial Solutions

Press Release April 20, 2026

ConcertAI Introduces Cadence Suite, Delivering Industry Leading Visibility and Predictive Insights into the Patient’s Journey for Commercial Teams

Press Release March 25, 2026

ConcertAI Appoints Missy Jerome as Chief People Officer

Press Release February 1, 2026

ConcertAI Launches Accelerated Clinical Trials, Leveraging Agentic AI to Radically Shorten Trial Timelines

Press Release January 11, 2026

ConcertAI and Foundation Medicine Integrate Genomic and Clinical Data to Transform Translational Research and Efficient Drug Development

Press Release November 19, 2025

ConcertAI’s TeraRecon DETECT™ Helps Identify Opportunities to Optimize AI Imaging Reimbursement Workflows, Expanding Patient Access to the Most Advanced Care

Press Release November 19, 2025

ConcertAI Introduces TeraRecon AV™*, Advancing AI-Powered Medical Imaging with New Structural Heart and SaaS Capabilities

Press Release October 19, 2025

ConcertAI Appoints Dr. Shaalan Beg as Chief Medical Officer, Oncology

Press Release September 24, 2025

ConcertAI’s TeraRecon Surpasses 2,000 Global Customers, Accelerating Cloud-First SaaS Transformation to Further Unlock Productivity for Healthcare Providers

Press Release September 10, 2025

Casey Graves Joins ConcertAI as General Manager, Clinical Solutions

News Coverage September 1, 2025

Podcast: Cracking the Clinical Trial Code with ConcertAI's Jeff Elton

Press Release August 26, 2025

CancerLinQ Receives ASCO Certified RQS Recognition Enabling Automated Quality Tracking That Helps Oncology Care Practices Save Critical Time and Resources

Press Release August 17, 2025

ConcertAI Appoints Michael Myshrall as Chief Financial Officer

News Coverage July 17, 2025

Bringing together multiple AI tools could deliver more clinical value, says TeraRecon

News Coverage June 16, 2025

AITech Interview with Jeff Elton, Vice Chairman at ConcertAI

Press Release May 30, 2025

ConcertAI Provides Intelligent Automation of ASCO® Guidelines into its Generative and Agentic AI Precision Suite™ and CancerLinQ® SmartLinQ™ Solutions

Press Release May 29, 2025

ConcertAI Launches New Generative and Agentic Al-Powered Precision Suite™ Accelerating Oncology Insights and Actions for Healthcare and Life Sciences

Press Release April 30, 2025

ConcertAI Announces Leadership Transition to Accelerate AI Innovation and Growth

Press Release April 21, 2025

ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology

Press Release April 20, 2025

EY US unveils Jeff Elton of ConcertAI as an Entrepreneur Of The Year® 2025 New England Award finalist (English)

Press Release March 28, 2025

ConcertAI’s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers

News Coverage March 20, 2025

Inside NVIDIA and ConcertAI’s alliance to build AI agents for oncology trials

Press Release March 17, 2025

ConcertAI presents CARAai Multi-LLM and Agentic AI for Clinical Development and Insights at NVIDIA GTC 2025

Press Release February 24, 2025

RadNet’s Wholly-Owned Subsidiary, DeepHealth, and ConcertAI’s TeraRecon Announce Strategic Collaboration Around Integrated AI and Advanced Visualization (English)

Press Release February 2, 2025

At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors (English)

Press Release February 2, 2025

Exigent Research, Leading National Community Research Network, Partners with AI Leader ConcertAI to Integrate CARAai™ Precision Trial Solutions

News Coverage January 23, 2025

Guardant Health And ConcertAI Set Commercial Goals For Cancer Therapy Data-Sharing Deal

News Coverage January 23, 2025

The Definitive Guide to Artificial Intelligence Predictions for 2025 (English)

News Coverage January 15, 2025

24 Executive Healthcare AI Predictions & Trends to Watch in 2025

Press Release January 15, 2025

ConcertAI, Guardant Health Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development (English)

Press Release January 12, 2025

ConcertAI Presents at 43rd Annual J.P. Morgan Healthcare Conference: 2024 Results and 2025-2028 AI Solutions Roadmap

Press Release December 11, 2024

Dewpoint Therapeutics and ConcertAI Announce the First Phase of their Translational Oncology Partnership

News Coverage December 5, 2024

ConcertAI & NeoGenomics Announce AI SaaS for Hematology Clinical Research (English)

Press Release December 4, 2024

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research

Press Release December 1, 2024

ConcertAI Announces Cloud-Based SaaS Transformation of TeraRecon Portfolio, Expanding its AI-Enhanced Clinical Capabilities in Medical Imaging

Press Release October 22, 2024

TeraRecon’s New Intuition Product Line Delivers AI Productivity and Industry-leading Cardiac MR Workflows, All Delivered Through a Robust Software-as-a-Service (SaaS) Platform

Press Release September 30, 2024

ConcertAI Appoints James Salitan as General Counsel

Press Release June 5, 2024

Nick Jones Appointed SVP and GM Commercial Solutions (English)

Press Release June 3, 2024

2024 ASCO Annual Meeting study demonstrates that AI models for predicting patient availability for clinical trials showed a 2 – 4x improvement over traditional approaches

Press Release June 1, 2024

ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA (English)

Press Release May 30, 2024

ConcertAI introduces predictive and generative AI solutions powered by multi-modal real-world data, key partnerships, CARA AI, and more at the 2024 ASCO Annual Meeting

Press Release May 28, 2024

ASCO 2024 study uses ConcertAI Oncology Dataset to find earlier treatment with olaparib monotherapy may improve duration of therapy and overall survival (English)